FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices
Today, the Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging…